ADVM
Adverum Biotechnologies
ADVM
ADVM
Delisted
ADVM was delisted on the 8th of December, 2025.
63 hedge funds and large institutions have $32.5M invested in Adverum Biotechnologies in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
55% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
63
Holding in Top 10
–
Calls
–
Puts
$13K
Top Buyers
| 1 | +$5.47M | |
| 2 | +$818K | |
| 3 | +$771K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$551K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$535K |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$2.63M | |
| 3 | -$1.45M | |
| 4 |
CC
Casdin Capital
New York
|
-$1.13M |
| 5 |
State Street
Boston,
Massachusetts
|
-$899K |